Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-30

Clinical Trial Update: AngelMed Guardian® System PMA Post Approval Study

View source ↗

Summary

Angel Medical Systems is conducting a PMA post-approval study of the AngelMed Guardian System for Acute Coronary Syndrome. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AngelMed Guardian System

Snippet

Sponsor: Angel Medical Systems | Conditions: Acute Coronary Syndrome | Status: RECRUITING